Mr. Paul Levesque reports

THERATECHNOLOGIES TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS AND PROVIDE BUSINESS UPDATE

Theratechnologies Inc. will release its financial results and provide a business update for its second quarter ended May 31, 2023, on Wednesday, July 12, 2023, at 8:30 a.m. EDT.

The call will be hosted by Mr. Paul Levesque, President and Chief Executive Officer. Mr. Levesque will joined be other members of the management team, including Chief Financial Officer, Mr. Philippe Dubuc, Chief Medical Officer, Dr. Christian Marsolais and Global Commercial Officer, Mr. John Leasure, who will be available to answer questions from participants following prepared remarks.

Participants are encouraged to join the call at least ten minutes in advance to secure access.

Conference call dial-in and replay information is below:

CONFERENCE CALL INFORMATION

Conference Call Date July 12, 2023

Conference Call Time 8:30 a.m. EDT

Webcast link https://edge.media-server.com/mmc/p/ot7rcxmr

Dial in 1-888-317-6003 (toll free) or 1-412-317-6061 (international)

Access Code 0616524

An archived webcast will also be available on the Company's Investor Relations website under 'Past Events'.

About Theratechnologies

Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.